(11)Since it was not possible for the risk managers to conclude whether mecoprop-P is an endocrine disruptor in accordance with the scientific criteria for the determination of endocrine disrupting properties set out in points 3.6.5 and 3.8.2 of Annex II to Regulation (EC) No 1107/2009, as introduced by Commission Regulation (EU) 2018/605note, the Commission asked the Authority on 4 December 2018 to re-assess the existing information, to request additional information from the applicant if needed and to update its conclusion on the endocrine disrupting potential of mecoprop-P pursuant to Article 13(3a), first subparagraph, of Implementing Regulation (EU) No 844/2012. The Authority was also asked to review the risk assessment as regards non-dietary exposure to cover realistic agricultural practices.
Source: EUR-Lex, © European Union, 1998-2026. Reuse authorised under Decision 2011/833/EU.